EP0755262A4 - Composition for the treatment of lung disease - Google Patents

Composition for the treatment of lung disease

Info

Publication number
EP0755262A4
EP0755262A4 EP95913618A EP95913618A EP0755262A4 EP 0755262 A4 EP0755262 A4 EP 0755262A4 EP 95913618 A EP95913618 A EP 95913618A EP 95913618 A EP95913618 A EP 95913618A EP 0755262 A4 EP0755262 A4 EP 0755262A4
Authority
EP
European Patent Office
Prior art keywords
treatment
composition
lung disease
lung
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95913618A
Other languages
German (de)
French (fr)
Other versions
EP0755262A1 (en
Inventor
Philip Davies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0755262A1 publication Critical patent/EP0755262A1/en
Publication of EP0755262A4 publication Critical patent/EP0755262A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
EP95913618A 1994-03-11 1995-03-07 Composition for the treatment of lung disease Withdrawn EP0755262A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21242094A 1994-03-11 1994-03-11
US212420 1994-03-11
PCT/US1995/002938 WO1995024207A1 (en) 1994-03-11 1995-03-07 Composition for the treatment of lung disease

Publications (2)

Publication Number Publication Date
EP0755262A1 EP0755262A1 (en) 1997-01-29
EP0755262A4 true EP0755262A4 (en) 1997-05-07

Family

ID=22790936

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95913618A Withdrawn EP0755262A4 (en) 1994-03-11 1995-03-07 Composition for the treatment of lung disease

Country Status (5)

Country Link
EP (1) EP0755262A4 (en)
JP (1) JPH09510212A (en)
AU (1) AU686780B2 (en)
CA (1) CA2184385A1 (en)
WO (1) WO1995024207A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1755661T3 (en) * 2004-05-12 2014-06-16 Brigham & Womens Hospital GELSOLIN FOR USE FOR TREATMENT OF INFECTIONS
EP2001496B1 (en) 2006-03-15 2017-05-31 The Brigham And Women's Hospital, Inc. Use of gelsolin to diagnose and treat inflammatory diseases
CN112399860A (en) 2018-06-06 2021-02-23 麻省理工学院 Circular RNA for translation in eukaryotic cells
CA3139032A1 (en) 2019-05-22 2020-11-26 Robert Alexander WESSELHOEFT Circular rna compositions and methods
EP3920976B1 (en) 2019-12-04 2023-07-19 Orna Therapeutics, Inc. Circular rna compositions and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015770A1 (en) * 1990-04-11 1991-10-17 The General Hospital Corporation Therapeutic uses of actin-binding compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
IL99658A0 (en) * 1990-10-15 1992-08-18 Merck & Co Inc Substituted azetidinones and pharmaceutical compositions containing them
US5276139A (en) * 1991-08-26 1994-01-04 Merck & Co., Inc. Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015770A1 (en) * 1990-04-11 1991-10-17 The General Hospital Corporation Therapeutic uses of actin-binding compounds

Also Published As

Publication number Publication date
AU686780B2 (en) 1998-02-12
EP0755262A1 (en) 1997-01-29
CA2184385A1 (en) 1995-09-14
JPH09510212A (en) 1997-10-14
AU2099495A (en) 1995-09-25
WO1995024207A1 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
HK1000697A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
GB9421709D0 (en) Therapeutic compounds
HK1003711A1 (en) Therapeutic compounds
ZA953256B (en) Skin treatment composition
EP0777474A4 (en) Methods for the treatment of inflammatory joint disease
PL311916A1 (en) Pharmaceutic composition for treating skin diseases
IL114119A0 (en) Compositions and methods for the treatment of tumors
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
GB9414399D0 (en) Medical nebuliser
GB9405021D0 (en) Skin treatment composition
EP0755262A4 (en) Composition for the treatment of lung disease
EP0806962A4 (en) Methods for the treatment of acid aspiration-induced acute lung injury
IL113057A0 (en) Compositions for the treatment of dandruff
GB9510162D0 (en) Compositions for the treatment of skin conditions
EP0724842A3 (en) Preparation for the treatment of obesity
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA952120B (en) Skin treatment composition
AU6097394A (en) Method for the treatment of respiratory disease
ZA986324B (en) Composition for the treatment of immunodeficiency disease
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HU9700079D0 (en) Topical compositions for the treatment of skin disease
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
IL114089A0 (en) Methods for the preparation of alpha-chloroacetoacetanilide compounds
GB9407105D0 (en) Liver disease treatment
IL111296A0 (en) Diagnosis of lung condition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970319

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19971126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990128